RVC boards Covid research project

The Royal Veterinary College (RVC) has been awarded a grant worth almost £200,000 to join a collaborative research project that will examine companion animal susceptibility to coronavirus.

The study, named MASCOT (Mapping Animal Susceptibility to Coronavirus: Outcomes and Transcriptomics), will aim to achieve a greater understanding of why certain people are more susceptible to the illness, and work to identify new treatment targets.

The project, led by Professor Lucy Davison at the RVC, will examine two common veterinary coronaviruses, Canine Respiratory Coronavirus (CRCoV), which can contribute to ‘kennel cough’ in dogs, and Feline Enteric Coronavirus, which can lead to Feline Infectious Peritonitis (FIP) in cats. 

According to the RVC, both viruses share similarities with the virus that causes Covid-19, which means that studying these infections in pets could “provide new insights into coronavirus biology”.

Researchers from the RVC and the Universities of Cambridge, Oxford and Manchester will study genetic susceptibility to CRCoV and FIP, to understand which genes are involved in severe outcomes after naturally occurring coronavirus infections. 

The RVC says that ultimately, this understanding will help researchers identify new targets for coronavirus-associated disease prevention or treatment.

Professor Lucy Davison, Professor of Veterinary Clinical Genetics at the RVC, said: “At the moment, we do not know precisely why certain individuals are more susceptible to Covid-19, and whether this difference in susceptibility has a genetic basis. 

“This project will seek to address this gap in our knowledge by studying genetic susceptibility to the common coronaviruses that are treated by veterinary clinicians and, in doing so, pave the way for a greater overall understanding of COVID-19.”

She added: “At the RVC, we recognise the importance of a collaborative ‘One Health’ approach which operates at the cutting edge of veterinary and human medicine. 

“We look forward to working with colleagues at the University of Cambridge, the University of Oxford and the University of Manchester to improve our understanding of how to predict or treat severe coronavirus-associated conditions. We hope to make an important contribution to addressing the many challenges caused by the Covid-19 pandemic.”

Back to top button